Blocking apoptosis prevents blindness in Drosophila retinal degeneration mutants

F F Davidson1, H Steller

  • 1Howard Hughes Medical Research Institute, Massachusetts Institute of Technology, Cambridge 02139, USA.

Nature
|February 19, 1998
PubMed

Insights

Blocking apoptosis, a programmed cell death, can preserve function in degenerative diseases. Inhibiting apoptosis in mutant flies with retinal degeneration maintained their visual function, suggesting therapeutic potential.

Area of Science:

  • Cell Biology
  • Neuroscience
  • Genetics

Background:

  • Apoptosis is crucial for development but implicated in degenerative diseases.
  • Therapeutic strategies targeting apoptosis require understanding if rescued cells remain functional.
  • Age-related retinal degeneration models provide insights into cell death mechanisms.

Purpose of the Study:

  • To investigate the role of apoptosis in Drosophila retinal degeneration.
  • To determine if blocking apoptosis can preserve visual function in mutant flies.
  • To assess the therapeutic potential of inhibiting apoptosis in degenerative conditions.

Main Methods:

  • Utilized two Drosophila mutant strains (rdgC and ninaE(RH27)/+) exhibiting age-related retinal degeneration.
  • Induced apoptosis blockage using eye-specific expression of the baculoviral cell survival protein p35.
  • Assessed visual function retention in treated and untreated mutant flies.

Main Results:

  • Retinal cell death in the mutant flies was confirmed to occur via apoptosis.
  • Expression of p35 effectively blocked apoptosis in the fly retinas.
  • Flies expressing p35 demonstrated significant retention of visual function.

Conclusions:

  • Late-stage inhibition of apoptosis offers therapeutic benefits in flies with retinal degeneration.
  • Blocking apoptosis can lead to functional recovery in degenerating tissues.
  • These findings suggest potential therapeutic applications for inhibiting apoptosis in human degenerative diseases, including retinitis pigmentosa.